123
Views
7
CrossRef citations to date
0
Altmetric
Review

Molecular Basis for Pathogenicity of Human Coronaviruses

, &
Pages 2385-2405 | Published online: 17 Jul 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Chih-Kai Chang, Ming-Jr Jian, Hsing-Yi Chung, Jung-Chung Lin, Shan-Shan Hsieh, Sheng‐Hui Tang, Cherng-Lih Perng, Chien-Wen Chen, Kuo-Sheng Hung, Feng-Yee Chang & Hung-Sheng Shang. (2022) Clinical Comparative Evaluation of the LabTurboTM AIO® Reverse Transcription-Polymerase Chain Reaction and World Health Organization-Recommended Assays for the Detection of Emerging SARS-CoV-2 Variants of Concern. Infection and Drug Resistance 15, pages 595-603.
Read now
Elidamar Nunes de Carvalho Lima, Ana Luiza Moraes Octaviano, José Roberto Castilho Piqueira, Ricardo Sobhie Diaz & João Francisco Justo. (2022) Coronavirus and Carbon Nanotubes: Seeking Immunological Relationships to Discover Immunotherapeutic Possibilities. International Journal of Nanomedicine 17, pages 751-781.
Read now

Articles from other publishers (5)

David E. Scheim. (2022) A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody. International Journal of Molecular Sciences 23:5, pages 2558.
Crossref
Lisa Pagani, Clizia Chinello, Allia Mahajneh, Francesca Clerici, Lucrezia Criscuolo, Andrea Favalli, Paola Gruarin, Renata Grifantini, Alessandra Bandera, Andrea Lombardi, Riccardo Ungaro, Antonio Muscatello, Francesco Blasi, Andrea Gori & Fulvio Magni. (2022) Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome. BioChem 2:1, pages 64-83.
Crossref
John Charles Rotondo, Fernanda Martini, Martina Maritati, Chiara Mazziotta, Giulia Di Mauro, Carmen Lanzillotti, Nicole Barp, Altea Gallerani, Mauro Tognon & Carlo Contini. (2021) SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants. Viruses 13:9, pages 1687.
Crossref
Fatemeh Pourrajab. (2021) Targeting the glycans: A paradigm for host‐targeted and COVID‐19 drug design. Journal of Cellular and Molecular Medicine 25:13, pages 5842-5856.
Crossref
David Scheim. (2020) From Cold to Killer: How SARS-CoV-2 Evolved without Hemagglutinin Esterase to Agglutinate, Then Clot Blood Cells in Pulmonary and Systemic Microvasculature. SSRN Electronic Journal.
Crossref